{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:30:51Z","timestamp":1794479451460,"version":"4.9.1"},"reference-count":134,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,15]],"date-time":"2027-07-15T00:00:00Z","timestamp":1815609600000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1R01CA251608\\u201301"],"award-info":[{"award-number":["1R01CA251608\\u201301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1R01HG011356\\u201301"],"award-info":[{"award-number":["1R01HG011356\\u201301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"DOD","doi-asserted-by":"publisher","award":["CA180064"],"award-info":[{"award-number":["CA180064"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jhep.2026.03.029","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:07:22Z","timestamp":1774714042000},"page":"271-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global patterns of mutational profiles in biliary tract cancer"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3347-3045","authenticated-orcid":false,"given":"Yan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7562-9456","authenticated-orcid":false,"given":"Jason A.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4408-3357","authenticated-orcid":false,"given":"Dengyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0783-3959","authenticated-orcid":false,"given":"Saikat","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunyoung S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda","family":"Meric-Bernstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8605-0036","authenticated-orcid":false,"given":"Zishuo I.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Javle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8370-1432","authenticated-orcid":false,"given":"Lawrence N.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.03.029_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2026.03.029_bib2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2020.0930","article-title":"A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer","volume":"6","author":"Kim","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib3","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"The Lancet"},{"key":"10.1016\/j.jhep.2026.03.029_bib4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.03.029_bib5","article-title":"The recent trends of systemic treatments and locoregional therapies for cholangiocarcinoma","volume":"17","author":"Esmail","year":"2024","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.jhep.2026.03.029_bib6","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2026.03.029_bib7","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/hep.31862","article-title":"Molecular characterization of biliary tract cancer predicts chemotherapy and programmed death 1\/programmed death-ligand 1 blockade responses","volume":"74","author":"Yoon","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.03.029_bib8","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.7150\/thno.56539","article-title":"Mutational spectrum and precision oncology for biliary tract carcinoma","volume":"11","author":"Lin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jhep.2026.03.029_bib9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2026.03.029_bib10","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2026.03.029_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","article-title":"Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations","volume":"68","author":"Wardell","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.03.029_bib12","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Jiao","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2026.03.029_bib13","first-page":"3101","article-title":"Comprehensive genomic profile of cholangiocarcinomas in China","volume":"19","author":"Tian","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jhep.2026.03.029_bib14","article-title":"Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer","volume":"12","author":"Yu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5675020","article-title":"Somatic mutation profiling of intrahepatic cholangiocarcinoma: comparison between primary and metastasis tumor tissues","volume":"2020","author":"Xu","year":"2020","journal-title":"J Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/cncr.31850","article-title":"Regional differences in gallbladder cancer pathogenesis: insights from a multi-institutional comparison of tumor mutations","volume":"125","author":"Narayan","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2026.03.029_bib17","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1038\/ncomms6696","article-title":"Mutational landscape of intrahepatic cholangiocarcinoma","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.03.029_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7150\/thno.63417","article-title":"Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jhep.2026.03.029_bib19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.31829","article-title":"Genetic determinants of outcome in intrahepatic cholangiocarcinoma","volume":"74","author":"Boerner","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.03.029_bib20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jhep.2022.11.030","article-title":"Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma","volume":"78","author":"Kendre","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.03.029_bib21","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Li","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2026.03.029_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/cac2.12513","article-title":"Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase alpha (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma","volume":"44","author":"Liu","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.jhep.2026.03.029_bib23","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1038\/s41467-022-30708-7","article-title":"The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.03.029_bib24","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/2159-8290.CD-21-1640","article-title":"Geospatial immune heterogeneity reflects the diverse tumor-immune interactions in intrahepatic cholangiocarcinoma","volume":"12","author":"Lin","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2026.03.029_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2026.03.029_bib26","first-page":"2","article-title":"Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers","volume":"8","author":"Papadopoulou","year":"2018","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jhep.2026.03.029_bib27","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1038\/s41467-020-17880-4","article-title":"Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate","volume":"11","author":"Pandey","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.03.029_bib28","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.jhep.2026.03.029_bib29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/hep.32135","article-title":"Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas","volume":"75","author":"An","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.03.029_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2019.07.022","article-title":"Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker","volume":"120","author":"Chae","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhep.2026.03.029_bib31","doi-asserted-by":"crossref","first-page":"23825","DOI":"10.18632\/oncotarget.8183","article-title":"Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhep.2026.03.029_bib32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5009\/gnl210174","article-title":"Genetic, clinicopathological, and radiological features of intrahepatic cholangiocarcinoma with ductal plate malformation pattern","volume":"16","author":"Chung","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhep.2026.03.029_bib33","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ng.2806","article-title":"Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers","volume":"45","author":"Chan-On","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2026.03.029_bib34","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1158\/1078-0432.CCR-22-1954","article-title":"Comprehensive molecular characterization of gallbladder carcinoma and potential targets for intervention","volume":"28","author":"Giraldo","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2026.03.029_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.32150","article-title":"The immunogenomic landscape of resected intrahepatic cholangiocarcinoma","volume":"75","author":"Carapeto","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.03.029_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100824","article-title":"Population-specific immunogenomic alterations in gallbladder cancer and prognostic significance","volume":"38","author":"Zhu","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jhep.2026.03.029_bib37","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1002\/cncr.30254","article-title":"Biliary cancer: utility of next-generation sequencing for clinical management","volume":"122","author":"Javle","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2026.03.029_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/PO.18.00414","article-title":"Intrahepatic cholangiocarcinoma: genomic heterogeneity between eastern and western patients","volume":"4","author":"Cao","year":"2020","journal-title":"JCO Precision Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.03.029_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004135","article-title":"Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma","volume":"10","author":"Borad","year":"2014","journal-title":"Plos Genet"},{"key":"10.1016\/j.jhep.2026.03.029_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12859-016-1190-7","article-title":"Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data","volume":"17","author":"do Valle","year":"2016","journal-title":"BMC bioinformatics"},{"key":"10.1016\/j.jhep.2026.03.029_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-4939-8666-8_7","article-title":"Split-read indel and structural variant calling using PINDEL","volume":"1833","author":"Ye","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhep.2026.03.029_bib43","article-title":"Benchmarking germline CNV calling tools from exome sequencing data","volume":"11","author":"Gordeeva","year":"2021","journal-title":"Scientific Rep"},{"key":"10.1016\/j.jhep.2026.03.029_bib44","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/gb-2013-14-2-r12","article-title":"SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data","volume":"14","author":"Jia","year":"2013","journal-title":"Genome Biol"},{"key":"10.1016\/j.jhep.2026.03.029_bib45","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2026.03.029_bib46","series-title":"Biological validation of RNA sequencing data from formalin-fixed paraffin-embedded primary melanomas","first-page":"2018","author":"Kwong","year":"2018"},{"key":"10.1016\/j.jhep.2026.03.029_bib47","series-title":"Generalized linear models","author":"McCullagh","year":"2019"},{"key":"10.1016\/j.jhep.2026.03.029_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.jhep.2026.03.029_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clin trials"},{"key":"10.1016\/j.jhep.2026.03.029_bib50","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jhep.2026.03.029_bib51","series-title":"Categorical data analysis","author":"Agresti","year":"2013"},{"key":"10.1016\/j.jhep.2026.03.029_bib52","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/2159-8290.CD-23-0282","article-title":"An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS-mutant intrahepatic cholangiocarcinoma","volume":"13","author":"Zhang","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2026.03.029_bib53","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1038\/s41467-024-54387-8","article-title":"Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.03.029_bib54","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1158\/1078-0432.CCR-22-2036","article-title":"FDA approval summary: pemigatinib for previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusion or other rearrangement","volume":"29","author":"Patel","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2026.03.029_bib55","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1158\/1078-0432.CCR-21-4462","article-title":"FDA approval summary: ivosidenib for the treatment of patients with advanced unresectable or metastatic, chemotherapy refractory cholangiocarcinoma with an IDH1 mutation","volume":"28","author":"Casak","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2026.03.029_bib56","first-page":"OF1","article-title":"Assessing patient risk, benefit, and outcomes in drug development: a decade of dabrafenib and trametinib clinical trials","author":"Jhanji","year":"2025","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jhep.2026.03.029_bib57","first-page":"1","article-title":"Zanidatamab: first approval","author":"Keam","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.jhep.2026.03.029_bib58","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12885-021-07792-x","article-title":"Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhep.2026.03.029_bib59","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/jjco\/hyaa088","article-title":"Characteristics of genomic alterations in Chinese cholangiocarcinoma patients","volume":"50","author":"Jiang","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1158\/2326-6066.CIR-21-1101","article-title":"Molecular subgroups of intrahepatic cholangiocarcinoma discovered by single-cell RNA sequencing\u2013assisted multiomics analysis","volume":"10","author":"Bao","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jhep.2026.03.029_bib61","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1158\/1078-0432.CCR-19-0127","article-title":"Alterations in DNA damage repair genes in primary liver cancer","volume":"25","author":"Lin","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2026.03.029_bib62","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/hep.30493","article-title":"Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma","volume":"69","author":"Goeppert","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.03.029_bib63","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3390\/jcm9092854","article-title":"Molecular profiling in daily clinical practice: practicalities in advanced cholangiocarcinoma and other biliary tract cancers","volume":"9","author":"Lamarca","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhep.2026.03.029_bib64","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.29764","article-title":"Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma","volume":"68","author":"Nepal","year":"2018","journal-title":"Hepatology"},{"issue":"4.2","key":"10.1016\/j.jhep.2026.03.029_bib65","article-title":"Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities","volume":"58","author":"Goeppert","year":"2020","journal-title":"Z f\u00fcr Gastroenterologie"},{"key":"10.1016\/j.jhep.2026.03.029_bib66","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/gutjnl-2020-322983","article-title":"Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis","volume":"71","author":"Goeppert","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2026.03.029_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1723","article-title":"Integrative genomic analyses of European intrahepatic cholangiocarcinoma: novel ROS1 fusion gene and PBX1 as prognostic marker","volume":"14","author":"Plum","year":"2024","journal-title":"Clin Translational Med"},{"key":"10.1016\/j.jhep.2026.03.029_bib68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40164-023-00470-7","article-title":"Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA","volume":"13","author":"Astier","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib69","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"Simbolo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhep.2026.03.029_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ccell.2017.05.009","article-title":"Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma","volume":"32","author":"Chaisaingmongkol","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2026.03.029_bib71","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ng.2273","article-title":"Exome sequencing of liver fluke\u2013associated cholangiocarcinoma","volume":"44","author":"Ong","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2026.03.029_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153806","article-title":"Genomic profiling of gallbladder carcinoma: targetable mutations and pathways involved","volume":"232","author":"Mishra","year":"2022","journal-title":"Pathology-Research Pract"},{"key":"10.1016\/j.jhep.2026.03.029_bib73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.mjafi.2024.01.006","article-title":"Heterogeneous ERBB gene pathways, their targeted treatment and possible molecular mechanisms of resistance in metastatic gallbladder cancer","volume":"81","author":"Patel","year":"2025","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.jhep.2026.03.029_bib74","first-page":"495","article-title":"Targeted gene sequencing of gallbladder carcinoma identifies high-impact somatic and rare germline mutations","volume":"14","author":"Yadav","year":"2017","journal-title":"Cancer Genom Proteom"},{"key":"10.1016\/j.jhep.2026.03.029_bib75","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1097\/JS9.0000000000002031","article-title":"Genomic landscape of gallbladder cancer: insights from whole exome sequencing","volume":"110","author":"Awasthi","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.jhep.2026.03.029_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100301","article-title":"Diagnostic utility of next-generation sequencing in circulating free DNA and a comparison with matched tissue in gallbladder carcinoma","volume":"104","author":"Mishra","year":"2024","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2026.03.029_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6616062","article-title":"Prognostic value of inflammatory and tumour markers in small-duct subtype intrahepatic Cholangiocarcinoma after curative-intent resection","volume":"2021","author":"Ma","year":"2021","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jhep.2026.03.029_bib78","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/14737159.2023.2205588","article-title":"Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features","volume":"23","author":"Chen","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jhep.2026.03.029_bib79","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/liv.16015","article-title":"Integrative analysis reveals different feature of intrahepatic cholangiocarcinoma subtypes","volume":"44","author":"Chen","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.03.029_bib80","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jhep.2026.03.029_bib81","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/PAS.0000000000002224","article-title":"An immunohistochemical analysis of osteopontin and S100 Calcium-binding protein P is useful for subclassifying Large-and Small-duct type intrahepatic cholangiocarcinomas","volume":"48","author":"Yoshizawa","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2026.03.029_bib82","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.hpb.2018.07.021","article-title":"Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma","volume":"21","author":"Akita","year":"2019","journal-title":"Hpb"},{"key":"10.1016\/j.jhep.2026.03.029_bib83","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1245\/s10434-023-14833-1","article-title":"Impact of tumor subclassifications for identifying an appropriate surgical strategy in patients with intrahepatic cholangiocarcinoma","volume":"31","author":"Kinoshita","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib84","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/RCT.0000000000000695","article-title":"Intrahepatic mass-forming cholangiocarcinoma: relationship between computed tomography characteristics and histological subtypes","volume":"42","author":"Nam","year":"2018","journal-title":"J Comput Assist tomography"},{"key":"10.1016\/j.jhep.2026.03.029_bib85","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000521747","article-title":"Subtype classification of intrahepatic cholangiocarcinoma using liver MR imaging features and its prognostic value","volume":"11","author":"Park","year":"2022","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jhep.2026.03.029_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2025.152515","article-title":"Small but significant: prognostic value of the small duct type in intrahepatic cholangiocarcinoma","author":"Kim","year":"2025","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.jhep.2026.03.029_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154126","article-title":"Impact of small duct-and large duct type on survival in patients with intrahepatic cholangiocarcinoma: results from a German tertiary center","volume":"238","author":"Kinzler","year":"2022","journal-title":"Pathology-Research Pract"},{"key":"10.1016\/j.jhep.2026.03.029_bib88","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3390\/cancers14133156","article-title":"Integrative analysis of intrahepatic cholangiocarcinoma subtypes for improved patient stratification: clinical, pathological, and radiological considerations","volume":"14","author":"Gerber","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jhep.2026.03.029_bib89","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jcp-2024-209429","article-title":"Combined analysis of albumin in situ hybridisation and C reactive protein immunohistochemistry for the diagnosis of intrahepatic cholangiocarcinoma: towards a molecular classification paradigm","volume":"78","author":"Albrecht","year":"2025","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jhep.2026.03.029_bib90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/jclinpath-2019-206055","article-title":"Cholangiolar pattern and albumin in situ hybridisation enable a diagnosis of intrahepatic cholangiocarcinoma","volume":"73","author":"Brackett","year":"2020","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jhep.2026.03.029_bib91","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/PAS.0000000000001118","article-title":"Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns","volume":"42","author":"Sigel","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2026.03.029_bib92","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00428-024-03787-8","article-title":"Prognostic implications of tumor histology and microenvironment in surgically resected intrahepatic cholangiocarcinoma: a single institutional experience","volume":"486","author":"Chen","year":"2025","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.jhep.2026.03.029_bib93","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41698-024-00720-9","article-title":"Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients","volume":"8","author":"Hong","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2022.1610360","article-title":"Molecular landscape of ERBB2 alterations in 14,956 solid tumors","volume":"28","author":"Wang","year":"2022","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.jhep.2026.03.029_bib95","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-17-1452","article-title":"Allele-specific mechanisms of activation of MEK1 mutants determine their properties","volume":"8","author":"Gao","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2026.03.029_bib96","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41588-024-02039-4","article-title":"Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations","volume":"57","author":"Funk","year":"2025","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2026.03.029_bib97","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41588-024-01799-3","article-title":"Saturation genome editing of BAP1 functionally classifies somatic and germline variants","volume":"56","author":"Waters","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2026.03.029_bib98","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-024-08349-1","article-title":"Saturation genome editing-based clinical classification of BRCA2 variants","volume":"638","author":"Sahu","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.03.029_bib99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","article-title":"Accurate classification of BRCA1 variants with saturation genome editing","volume":"562","author":"Findlay","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.03.029_bib100","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1016\/j.cell.2025.05.046","article-title":"Functional assessment of all ATM SNVs using prime editing and deep learning","volume":"188","author":"Lee","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2026.03.029_bib101","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajhg.2018.03.018","article-title":"A saturation mutagenesis approach to understanding PTEN lipid phosphatase activity and genotype-phenotype relationships","volume":"102","author":"Mighell","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jhep.2026.03.029_bib102","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.95347.4","article-title":"Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity","volume":"13","author":"Kimura","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.jhep.2026.03.029_bib103","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/1541-7786.MCR-20-0721","article-title":"Colorectal cancer-associated Smad4 R361 hotspot mutations boost Wnt\/\u03b2-catenin signaling through enhanced smad4\u2013LEF1 binding","volume":"19","author":"Lanauze","year":"2021","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jhep.2026.03.029_bib104","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1093\/nar\/gkz058","article-title":"The WD40 domain of FBXW7 is a poly (ADP-ribose)-binding domain that mediates the early DNA damage response","volume":"47","author":"Zhang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2026.03.029_bib105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12010-021-03759-7","article-title":"Comprehensive study of human FBXW7 deleterious nsSNP\u2019s functional inference and susceptibility to gynaecological cancer","volume":"194","author":"Vasuki","year":"2022","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.jhep.2026.03.029_bib106","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v21.i45.12896","article-title":"Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: a systematic review","volume":"21","author":"Fiorino","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2026.03.029_bib107","article-title":"Molecular profiling of biliary tract cancers in african American and caucasian patients","volume":"9","author":"Hu","year":"2025","journal-title":"JCO precision Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib108","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4251\/wjgo.v4.i5.94","article-title":"Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity","volume":"4","author":"Cardinale","year":"2012","journal-title":"World J Gastrointest Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2026.03.029_bib109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.14093","article-title":"Anatomical, histomorphological and molecular classification of cholangiocarcinoma","volume":"39","author":"Kendall","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.03.029_bib110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.jhep.2026.03.029_bib111","doi-asserted-by":"crossref","first-page":"694","DOI":"10.6004\/jnccn.2023.0035","article-title":"NCCN Guidelines\u00ae insights: biliary tract cancers, version 2.2023","volume":"21","author":"Benson","year":"2023","journal-title":"J Natl Compr Cancer Netw : JNCCN"},{"key":"10.1016\/j.jhep.2026.03.029_bib112","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2026.03.029_bib113","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41588-023-01333-x","article-title":"Multiancestry genomic and transcriptomic analysis of gastric cancer","volume":"55","author":"Totoki","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2026.03.029_bib114","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ng.3006","article-title":"The genomic landscape of nasopharyngeal carcinoma","volume":"46","author":"Lin","year":"2014","journal-title":"Nat Genet"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2026.03.029_bib115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.03.029_bib116","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4251\/wjgo.v2.i11.407","article-title":"Intra-hepatic and extra-hepatic cholangiocarcinoma: new insight into epidemiology and risk factors","volume":"2","author":"Cardinale","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib117","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.3390\/cancers13164062","article-title":"Patterns of whole exome sequencing in resected cholangiocarcinoma","volume":"13","author":"Thornblade","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jhep.2026.03.029_bib118","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ijc.33230","article-title":"Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers","volume":"148","author":"Okamura","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2026.03.029_bib119","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw332","article-title":"Multiple roles of APC and its therapeutic implications in colorectal cancer","volume":"109","author":"Zhang","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2026.03.029_bib120","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41586-024-07205-6","article-title":"Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy","volume":"629","author":"Holderfield","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.03.029_bib121","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1158\/2159-8290.CD-24-0027","article-title":"Translational and therapeutic evaluation of RAS-GTP inhibition by RMC-6236 in RAS-driven cancers","volume":"14","author":"Jiang","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2026.03.029_bib122","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Cancer Genome Atlas","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2026.03.029_bib123","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature23291","article-title":"Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS","volume":"548","author":"Yao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.03.029_bib124","first-page":"1","article-title":"Response to pemigatinib in A patient with FGFR2 Y375C mutation \u2013 a case report and review of literature","volume":"5","author":"Dey","year":"2023","journal-title":"J Clin Cases"},{"key":"10.1016\/j.jhep.2026.03.029_bib125","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41698-021-00220-0","article-title":"Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma","volume":"5","author":"Bitzer","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jhep.2026.03.029_bib126","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyae294","article-title":"Efficacy of 2 different fibroblast growth factor receptor-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation: a case report","volume":"30","author":"Galli-Vareia","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.jhep.2026.03.029_bib127","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2159-8290.CD-20-0766","article-title":"Clinicogenomic analysis of FGFR2-rearranged cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib","volume":"11","author":"Silverman","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2026.03.029_bib128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.03.029_bib129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MOG.0000000000000611","article-title":"Molecular classification of cholangiocarcinoma","volume":"36","author":"Louis","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2026.03.029_bib130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/liv.13998","article-title":"Classifications and misclassification in cholangiocarcinoma","volume":"39","author":"Cardinale","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.03.029_bib131","article-title":"Mapping the landscape of biliary tract cancer in Europe: challenges and controversies","volume":"50","author":"Rimassa","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jhep.2026.03.029_bib132","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","article-title":"Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?","volume":"56","author":"Khan","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.03.029_bib133","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.03.029_bib134","article-title":"Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: the ENSCCA registries\u2019 framework for digital twin advancement","author":"Carpino","year":"202583753","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826001571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826001571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:55:19Z","timestamp":1794477319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":134,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0168827826001571"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.03.029","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global patterns of mutational profiles in biliary tract cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}